39 results
8-K
EX-2.1
QLGN
Qualigen Therapeutics Inc
26 Jul 23
Entry into a Material Definitive Agreement
5:25pm
health care programs (as defined therein), and any health insurance program for the benefit of federal employees, including those under 5 U.S.C … for, or payment or reimbursement for any health care items or services, including, without limitation: (i) the Federal Food, Drug, and Cosmetic Act, as amended (21
424B5
QLGN
Qualigen Therapeutics Inc
1 Dec 21
Prospectus supplement for primary offering
2:28pm
diagnostic products.
There is a COVID-19 pandemic.
COVID-19 has had, and will continue to have, adverse impacts on the U.S. and world economy, health … care systems, personnel availability, supply chains, social and political assumptions, and capital markets. Those impacts are expected to be especially
10-KT
zuiwk9y5p8ft
31 Mar 21
Annual report (with FYE transition)
4:33pm
424B5
86ucwjn qqiczr2
18 Dec 20
Prospectus supplement for primary offering
1:26pm
424B5
hmf3w1pl im4j
2 Oct 20
Prospectus supplement for primary offering
4:24pm
424B5
g5r3qg9hhw0hma
4 Aug 20
Prospectus supplement for primary offering
6:16am
424B5
9t9jfhohwu6np gq
10 Jul 20
Prospectus supplement for primary offering
2:35pm
8-K/A
EX-99.1
0nexm xcdqe
29 Jun 20
Index to Financial Statements
12:00am
424B3
7hmowut
9 Apr 20
Prospectus supplement
9:30am
S-4/A
d4rz3bpvs4olk k0
13 Mar 20
Registration of securities issued in business combination transactions (amended)
5:28pm
S-4/A
EX-10.59
vh8xcpn
13 Mar 20
Registration of securities issued in business combination transactions (amended)
5:28pm
S-4
ee4bpf5 s5z63t01riol
4 Feb 20
Registration of securities issued in business combination transactions
6:26am